Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?

Psychedelics extracted from plants have been used in religious, spiritual, and mystic practices for millennia. In 1957, Dr. Hofmann identified and synthesized the prodrug psilocybin, a substance present in more than 200 species of psychedelic mushrooms. Although there were limitations related to the...

Full description

Bibliographic Details
Published in:	Journal of Xenobiotics
Main Authors:	Maurizio Coppola, Francesco Bevione, Raffaella Mondola
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Subjects:	psilocybin psilocin psychedelics magic mushrooms
Online Access:	https://www.mdpi.com/2039-4713/12/1/4

Similar Items

Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans
by: Nilubon Thaoboonruang, et al.
Published: (2025-04-01)

The Therapeutic Potential of Psilocybin
by: Henry Lowe, et al.
Published: (2021-05-01)

Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models
by: Dotun Adeyinka, et al.
Published: (2025-08-01)

Psilocybin Use in an Intercollegiate Athlete with Persisting Symptoms After Concussion: A Case Report
by: David W. Lawrence, et al.
Published: (2025-07-01)

A Review of Synthetic Access to Therapeutic Compounds Extracted from <i>Psilocybe</i>
by: Raphaël Serreau, et al.
Published: (2022-12-01)

Manic episode following psilocybin use in a man with bipolar II disorder: a case report
by: Haniya J. Halim, et al.
Published: (2023-09-01)

Rediscovering Psilocybin as an Antidepressive Treatment Strategy
by: Rene Zeiss, et al.
Published: (2021-09-01)

Psychedelics, epilepsy, and seizures: a review
by: Ninon Freidel, et al.
Published: (2024-01-01)

The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov
by: Norring SA, et al.
Published: (2024-04-01)

In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin
by: Nathan T. Jones, et al.
Published: (2024-01-01)

Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity
by: Kinderlehrer DA
Published: (2025-01-01)

Exploring <i>Psilocybe cubensis</i> Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps
by: Eyal Kurzbaum, et al.
Published: (2025-01-01)

Psilocybin in the treatment of eating disorders: a systematic review of the literature and registered clinical trials
by: Francesco Bevione, et al.
Published: (2025-07-01)

Effects of Psilocin and Psilocybin on Human 5-HT<sub>4</sub> Serotonin and H<sub>2</sub> Histamine Receptors in Perfused Hearts of Transgenic Mice
by: Pauline Braekow, et al.
Published: (2025-07-01)

Neuroprotective effects of psilocybin in a rat model of stroke
by: Seong-Jin Yu, et al.
Published: (2024-10-01)

Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge
by: Karolina Wąsik, et al.
Published: (2023-12-01)

Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020–2021
by: Sofia Abramsky-Sze, et al.
Published: (2025-03-01)

Psilocybin-assisted therapy and HIV-related shame
by: Nicky J. Mehtani, et al.
Published: (2024-08-01)

Psilocybin and Mental Health–Don't Lose Control
by: Joseph M. Barnby, et al.
Published: (2018-07-01)

Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests
by: Grant Jones, et al.
Published: (2023-08-01)

Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertension
by: Grant M. Jones, et al.
Published: (2024-06-01)

Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals
by: Erin Wang, et al.
Published: (2024-11-01)

Refractory CRPS pain treated with psilocybin: A case report
by: David S. Jevotovsky, et al.
Published: (2024-09-01)

LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice
by: Gregory Ian Robinson, et al.
Published: (2025-03-01)

Effects of hallucinogenic drugs on the human heart
by: Joachim Neumann, et al.
Published: (2024-02-01)

LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain
by: J Van Der Walt, et al.
Published: (2023-11-01)

The Emergence of Psilocybin in Psychiatry and Neuroscience
by: Hossein Omidian, et al.
Published: (2025-04-01)

Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats
by: Filip Tylš, et al.
Published: (2023-06-01)

Psychedelics and psychiatric disorders: A emerging role
by: C. Peixoto, et al.
Published: (2021-04-01)

The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin
by: Tobias P. Whelan, et al.
Published: (2024-04-01)

Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”
by: Julia Bornemann, et al.
Published: (2024-06-01)

Novel Perspective of Medicinal Mushroom Cultivations: A Review Case for ‘Magic’ Mushrooms
by: Sarana Rose Sommano, et al.
Published: (2022-12-01)

Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy
by: Sara de la Salle, et al.
Published: (2024-07-01)

Evidence versus expectancy: the development of psilocybin therapy
by: James J. Rucker

Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perception
by: Stephanie Muller, et al.
Published: (2025-07-01)

The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review
by: Charles Palmer, et al.
Published: (2025-05-01)

Psilocybin for the treatment of posttraumatic stress disorder: A magic to treat a harmony of illusions?
by: Rakesh Khanna
Published: (2024-03-01)

Classic psychedelics do not affect T cell and monocyte immune responses
by: Deborah Rudin, et al.
Published: (2023-01-01)

Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors
by: Robertas Strumila, et al.
Published: (2021-11-01)

The Legal Perspective on Psilocybin for Medical Use in Czechia: A Key Milestone and the Case for Broader Consideration Beyond the Clinical Setting
by: Tereza Dlestikova
Published: (2025-09-01)